Breaking Down Yunnan Yuntianhua Co., Ltd. Financial Health: Key Insights for Investors

Curious whether Yunnan Yuntianhua Co., Ltd. (600096.SS) is a value play or a turning-point story? In Q3 2025 the company reported revenue of ¥12.61 billion (down 14.42% year‑over‑year) with TTM revenue at ¥52.41 billion (down 16.12% Y/Y), while market capitalization stood at ¥55.89 billion as of November 27, 2025; yet profitability signals contrast the top‑line pressure - Q3 net profit attributable to shareholders was ¥1.97 billion (up 24.3% Y/Y) with EPS of ¥1.078 (+24.91%), a trailing P/E of 7.90, P/S of 0.67 and P/B of 1.71, operating margin (TTM as of Mar 31, 2025) at 12.09%, ROE (TTM) at 23.11% and cash at bank of ¥8.26 billion (Mar 31, 2024), against a backdrop of a strategic pullback from trading, a 40.09% state ownership stake, recent share repurchases and both regulatory and commodity price risks - read on for a chapter‑by‑chapter financial breakdown and what these real figures mean for investors.

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Revenue Analysis

• Q3 2025 revenue: ¥12.61 billion (down 14.42% YoY vs Q3 2024).
• TTM revenue (as of Sep 30, 2025): ¥52.41 billion (down 16.12% YoY).
• Annual revenue 2024: ¥61.54 billion (decline of 10.89% vs 2023).
• Revenue per share (TTM, Sep 2025): ¥6.92, reflecting a 12-month decline.
• Market capitalization (as of Nov 27, 2025): ¥55.89 billion.

• Primary driver: strategic reduction in trading operations to concentrate resources on core fertilizer and chemical segments, reducing volatile trading revenue but aiming to stabilize margins.
• Short-term impact: lower headline revenue and revenue-per-share metrics; potential improvement in revenue quality and margin consistency over time.
• Investor considerations: monitor quarterly trends for evidence of margin recovery, inventory adjustments, and the pace of trading-scale reduction.

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Profitability Metrics

Key profitability indicators for Yunnan Yuntianhua Co., Ltd. highlight improving margins, stronger bottom-line growth in 2024-Q3 2025, and efficient capital use through trailing‑twelve‑month measures as of March 31, 2025. Refer to the company context and strategic outlook: Mission Statement, Vision, & Core Values (2026) of Yunnan Yuntianhua Co., Ltd.

• Q3 2025 net profit attributable to shareholders: ¥1.97 billion, up 24.3% year-over-year.
• Q3 2025 basic EPS: ¥1.078, up 24.91% year-over-year.
• Net profit margin (FY 2024): 8.7%, improved from 6.5% in FY 2023-evidence of better cost management.
• Operating margin (TTM as of 2025-03-31): 12.09%.
• Return on assets (TTM as of 2025-03-31): 8.07%; Return on equity (TTM as of 2025-03-31): 23.11%.
• Reported profit margin for fiscal year ending 2024-12-31: 8.51%.

• Improvement drivers: margin expansion from 2023→2024, one‑time and recurring cost controls, and stronger EPS performance in Q3 2025.
• Investor implications: elevated ROE (23.11% TTM) signals effective equity utilization; operating margin above 12% TTM supports sustainable earnings generation.

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Debt vs. Equity Structure

Yunnan Yuntianhua's capital structure shows a pronounced mix of state control and public-market participation, with recent share repurchases and asset base figures that investors should weigh alongside incomplete public disclosure on certain leverage ratios.

• Total assets (as of March 31, 2025): ¥7.1 billion
• Market capitalization (as of July 1, 2025): ¥40.45 billion
• Largest shareholder - Yunnan State-Owned Assets Supervision and Administration Commission: 40.09% stake
• 2023 share repurchase: 11,338,016 shares (0.62% of total shares) for ¥199.97 million
• Debt-to-equity ratio: not explicitly provided in available sources

Key considerations for investors:

• High market cap relative to reported assets suggests significant market pricing of future earnings, intangibles, or state-backed value.
• State majority stake (40.09%) creates governance and strategic implications - potential support but also state policy influence.
• Repurchase activity (¥199.97 million in 2023) signals management willingness to deploy cash for shareholder returns and to concentrate ownership.
• Absent an explicit debt-to-equity ratio, investors should review balance-sheet details (short- and long-term borrowings, net debt) in filings to assess leverage and interest coverage.

For broader shareholder composition, trading patterns, and historical ownership shifts, see: Exploring Yunnan Yuntianhua Co., Ltd. Investor Profile: Who's Buying and Why?

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Liquidity and Solvency

Key liquidity datapoints and solvency notes for Yunnan Yuntianhua Co., Ltd. (600096.SS) based on available disclosures and filings.

• Cash holdings rose from ¥6.43 billion to ¥8.26 billion between Dec 31, 2023 and Mar 31, 2024.
• The increase of ¥1.83 billion suggests strengthened short-term liquidity.
• Improved liquidity enhances the company's ability to meet near-term obligations and operational needs.
• Absent published current ratio and detailed liability schedules, comprehensive solvency assessment is not possible from available data alone.

For broader context on the company's background and operations, see: Yunnan Yuntianhua Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Valuation Analysis

• Trailing P/E (TTM): 7.90 - below broad chemical/industrial benchmarks, suggesting potential undervaluation.
• Forward P/E: 7.60 - market expects only modest change in earnings, maintaining a low forward multiple.
• P/S (TTM): ¥0.67 - low revenue multiple, consistent with discounted market valuation.
• P/B (most recent quarter): ¥1.71 - implies the market prices the company's net assets at a premium to book.
• EV/Revenue: 0.81 - enterprise-level valuation under 1x revenue, indicating low price relative to generated sales.
• EV/EBITDA: 5.24 - modest multiple suggesting reasonable enterprise profitability relative to value.

• Relative perspective: the combination of low P/E, low P/S and sub-1x EV/Revenue indicates the stock trades at materially lower multiples than many peers in chemicals/industrial sectors.
• Asset valuation tension: P/B at 1.71 shows the market assigns a premium to reported book equity despite low earnings multiples - review balance-sheet composition, intangible assets, revaluations, and recent impairments.
• Investor takeaways: low equity and enterprise multiples support a value-investor thesis but warrant due diligence on earnings quality, cyclical exposure, and asset risks (capex, environmental, commodity prices).

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Risk Factors

• Declining revenue: reported top-line contraction over the past year that may reflect weakening trading operations, softer domestic demand, or inventory/marketing inefficiencies.
• Significant state ownership: majority/state-linked shareholdings create potential for policy-driven decisions or government intervention that could alter capital allocation, M&A, or pricing strategies.
• Environmental and regulatory pressure: tightening emissions, wastewater and land remediation rules in China raise compliance capex and operating costs for the chemical fertilizer sector.
• Raw material volatility: phosphate rock, sulfur and ammonia feedstock price swings materially affect gross margins and working-capital requirements.
• International exposure: exports and overseas assets introduce geopolitical, trade-policy and FX risks that can erode reported profits and cashflows.
• Intense competition: domestic consolidation and low-cost international competitors can pressure market share, margins and pricing power.

Key quantitative indicators illustrating these risks (recent fiscal trend snapshot):

• Revenue decline interpretation: a ~16% y/y fall in 2023 (from 2022) signals margin squeeze and weaker trading; management inventory days and receivable days should be monitored for signs of trading stress.
• Balance-sheet levers: rising debt ratio (to ~58%) together with falling operating cash flow indicates tighter liquidity - potential need for working-capital financing or asset disposals.
• Commodity sensitivity: a +/-20% move in phosphate/ammonia prices can swing annual EBITDA materially; hedging policies and fixed‑price contracts are key mitigants.
• Regulatory capex risk: estimated additional environmental CAPEX and remediation could require several hundred million RMB commitments in near-term years, impacting free cash flow.
• FX and geopolitical exposures: significant export percentages or foreign-held receivables magnify the impact of RMB moves and trade barriers on reported earnings.
• Competitive pressure: domestic overcapacity and low-cost imports may force spot pricing down, pressuring utilization and spreads.

Actionable monitoring checklist for investors:

• Quarterly revenue and selling-price trends vs. input-cost indices (phosphate, ammonia, sulfur).
• Operating cash flow and working-capital cycle (inventory/AR/AP days).
• CAPEX and environmental-provision roll-forward and timetable.
• Changes in major shareholder structure or government directives (capital injections, asset transfers).
• Hedging disclosures and foreign‑currency exposure.
• Market-share moves vs. domestic peers and imported product volumes.

Further context on company purpose and strategic framing is available here: Mission Statement, Vision, & Core Values (2026) of Yunnan Yuntianhua Co., Ltd.

Yunnan Yuntianhua Co., Ltd. (600096.SS) - Growth Opportunities

• Analyst-backed growth: consensus forecasts indicate a 5.1% CAGR in revenue for the next three years, implying compounded upside for top-line performance and operating leverage.
• Sustainability tailwinds: emphasis on low-emission production processes and premium "high-quality" fertilizer products aligns with global agri-environmental standards, enabling access to ESG-sensitive buyers and premium pricing.
• Strategic M&A: the minority stake in Yunnan Phosphate Chemical Group Co., Ltd. strengthens feedstock and distribution synergies, potentially lowering feedstock cost volatility and improving margin stability.
• Geographic expansion: intensified commercial efforts in Southeast Asia and the Middle East target higher-growth agricultural markets and can dilute domestic cyclicality risk.
• R&D-led product mix upgrade: continued investment into innovative fertilizer formulations (controlled-release, specialty micronutrients) can increase ASPs and reduce commodity exposure.
• Brand and supply-chain efficiency: improvements in logistics, inventory turns and brand recognition can compound profit expansion even at moderate revenue growth rates.

• Quantifiable R&D pathway: allocating even 0.5-1.0% of revenue to targeted R&D can accelerate specialty-product mix growth and lift average selling prices over a multi-year horizon.
• M&A value capture: minority equity positions in upstream or regional distributors can translate to 2-4% incremental EBITDA uplift if integration reduces input costs and improves channel margins.
• Market-entry scale effects: establishing footholds in two medium-size Southeast Asian markets could contribute an incremental 3-6% to consolidated sales within 3-5 years, depending on execution.